BetterLife Pharma Inc.
BETRF
$0.11
$0.0330.67%
OTC PK
| 01/31/2026 | 10/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.65% | -26.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.87% | -24.68% | |||
| Operating Income | -14.87% | 24.68% | |||
| Income Before Tax | 7.10% | 17.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.10% | 17.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -90.00% | 14.29% | |||
| Net Income | 4.82% | 18.09% | |||
| EBIT | -14.87% | 24.68% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.00% | 20.83% | |||
| Normalized Basic EPS | 0.00% | 20.00% | |||
| EPS Diluted | 13.64% | 8.33% | |||
| Normalized Diluted EPS | 0.00% | 20.00% | |||
| Average Basic Shares Outstanding | -0.24% | 1.44% | |||
| Average Diluted Shares Outstanding | -0.24% | 1.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||